Researcher spotlights changes in treatment of ALL
103 views | Added 2012-12-20 | Rate Sign in to rate
ATLANTA Matt Kalaycio, MD, director of the Bone Marrow Transplant Program at Taussig Cancer Institute at Cleveland Clinic, reacts to the findings of two studies that addressed the role of autologous vs. allogeneic transplantation in patients with acute lymphoblastic leukemia.
View more stories like this
This collection is currently empty.